𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cytomegalovirus infection in AIDS. Patterns of disease, response to therapy and trends in survival

✍ Scribed by B.S. Peters; E.J. Beck; S. Anderson; D. Coleman; R. Coker; J. Main; C. Migdal; J.R.W. Harris; A.J. Pinching

Publisher
Elsevier Science
Year
1991
Tongue
English
Weight
572 KB
Volume
23
Category
Article
ISSN
0163-4453

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Antibody response to human cytomegalovir
Antibody response to human cytomegalovirus (HCMV) glycoprotein B (gB) in AIDS patients with HCMV end-organ disease
✍ Alberola, Juan; DomΓ­nguez, Victoria; CardeΓ±oso, Laura; LΓ³pez-Aldeguer, Jose; Bla πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 87 KB πŸ‘ 2 views

Human cytomegalovirus (HCMV)-specific antibody responses in HIV-1 infected individuals either with or without HCMV end-organ disease were examined to determine the whether development of HCMV disease was associated with a particular deficit in the antibody response. Antiwhole HCMV, anti-glycoprotein

Changing seroepidemiological patterns of
Changing seroepidemiological patterns of cytomegalovirus infection in children in Taiwan from 1984 to 1989
✍ Ping-Ing Lee; Mei-Hwei Chang; Chin-Yun Lee; Chuan-Lian Kao πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 410 KB

## Abstract The prevalence of cytomegalovirus (CMV) antibody was studied in 966 children in 1984 and 927 children in 1989. The overall prevalence rate of CMV antibody was 59% for children in 1984 and 46% for children in 1989 (__P__ < 0.05). In both study years, the prevalence rate of CMV antibody w

Factors predictive of response to interf
Factors predictive of response to interferon-Ξ± therapy in hepatitis C virus infection
✍ Akihito Tsubota; Kazuaki Chayama; Kenji Ikeda; Arase Yasuji; Isao Koida; Satoshi πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 759 KB

To determine the patient-dependent and virusrelated factors that may predict sustained response to interferon-a therapy, we prospectively evaluated 60 consecutive patients with chronic hepatitis C who received a standardized treatment schedule of interferon-a. Twenty-eight patients achieved a long-t